Stockreport

Maze Therapeutics Announces Oversubscribed $150.0 Million Private Placement [Yahoo! Finance]

Maze Therapeutics, Inc.  (MAZE) 
PDF Therapeutics, Inc. (Nasdaq: MAZE), a clinical-stage biopharmaceutical company developing small molecule precision medicines for patients with kidney and metabolic diseas [Read more]